CGN Nuclear Technology Development Co., Ltd.

CGN Nuclear Technology Development Co., Ltd. (CGNNT) is a prominent subsidiary of China General Nuclear Power Corporation (CGN) and operates as a strategic platform for the industrialization of nuclear technology applications. Established in 1998 and listed on the Shenzhen Stock Exchange, CGNNT focuses on developing and commercializing nuclear technologies, positioning itself as a leader in this specialized sector. The company has established a comprehensive domestic business framework centered on three main areas: electron accelerator manufacturing, irradiation processing services, and modified polymer materials. CGNNT is recognized as the largest industrial electron accelerator manufacturer in China, with significant R&D capabilities and a wide range of product offerings. Its products serve various industries, including nuclear power, new energy, and aerospace. Additionally, CGNNT is involved in emerging sectors such as nuclear medicine and international trade, while also maintaining a strong presence in the domestic market for high-end cable materials and irradiation processing services.

CGN Nuclear Technology Development Co., Ltd. (CGNNT) is a leading nuclear technology application company, and was re-listed on Shenzhen Stock Exchange on Feb 27, 2017 after CGN Nuclear Technology Application Co., Ltd. and China Dalian International Cooperation (Group) Holding Ltd. underwent major asset restructuring. The company is the first listed nuclear technology application company in China and also the first A-share listed company of China General Nuclear Power Corporation (CGN). CGNNT, a subsidiary of CGN, serves as a strategic platform for industrialization of developing nuclear technology applications. At present, the company has formed a domestic business layout featuring three core fields of electron accelerator manufacturing, irradiation processing service and modified polymer material and is actively expanding the international market. In the meanwhile, the company is steadily pushing forward emerging businesses such as nuclear medicine, nuclear instrumentation and equipment, and new applications of irradiation processing. With the principle of sustainable development featuring "high return on investment, high market potential, high technological added value, high social value and rapid growth for staff", the company always takes talents, technology and culture as its core competitiveness and commits itself to becoming a leader in nuclear technology application industry in China.